Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Glyceraldehyde-3-phosphate dehydrogenase pseudogene 30 (GAPDHP30)
- Target
- GAPDHP30
- Molecular classification
- Pseudogene
01
Overview
GAPDHP30 is one of many processed pseudogenes related to the GAPDH gene, which encodes an important glycolytic enzyme. Pseudogenes arise by retrotransposition events from their parent gene transcripts and are prevalent for highly expressed housekeeping genes such as GAPDH, resulting in dozens of pseudogene copies in the human genome. GAPDHP30 itself is a non-protein-coding genomic segment, sequence-related to GAPDH but lacking the ability to encode a functional protein due to disablements such as insertions, deletions, or nonsense mutations. While some pseudogenes can influence gene regulation or genomic architecture, there are no reported biological functions, disease roles, or therapeutic interactions specifically for GAPDHP30. Its significance lies mainly in illustrating the evolutionary dynamics of gene duplication and retrotransposition in the human genome.
- Other names
- Glyceraldehyde-3-phosphate dehydrogenase pseudogene 30GAPDHP30
02
Mechanism of action
Not applicable. As a pseudogene, GAPDHP30 does not mediate any mechanism of drug action.
03
Biological functions
As a pseudogene, GAPDHP30 does not encode an active enzyme or receptor.Pseudogenes as a class may play passive roles as genetic fossils.In some cases (not specifically shown for GAPDHP30), pseudogenes may have regulatory functions such as mRNA binding/regulation of the parent gene.In rare cases (not specifically shown for GAPDHP30), pseudogenes may be involved in chromosomal recombination/gene conversion.
04
Disease associations
Pseudogenes can sometimes be implicated in genomic instability or recombination events.Rarely, gene conversion leading to disease (not established for GAPDHP30).
Beyond the preview
Go deeper on Glyceraldehyde-3-phosphate dehydrogenase pseudogene 30 (GAPDHP30).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Glyceraldehyde-3-phosphate dehydrogenase pseudogene 30 (GAPDHP30).